500
Y.-M. Chiang et al. / Phytochemistry 66 (2005) 495–501
in hexane to afford compounds 1 (12 mg), 5 (7 mg), and
7 (11 mg). Fr. 6 was separated by preparative HPLC
[Phenomenex Luna 5 lm Silica (2), 250 mm · 10 mm]
eluted with 20% EtOAc in hexane to afford compounds
2 (11 mg), 4 (5 mg), 6 (33 mg), 8 (18 mg), and 10
(15 mg). Fr. 7 (13.3 g) was subjected to Si gel cc
(5 · 30 cm) eluted with CH2Cl2–MeOH mixtures of
increasing polarity (1:0, fr. 7-1, 500 ml; 49:1, fr. 7-2,
1500 ml; 19:1, fr. 7-3, 1000 ml; 9:1, fr. 7-4, 500 ml). Fr.
7-2 was separated by preparative HPLC [Phenomenex
Luna 5 lm Silica (2), 250 mm · 10 mm] eluted with
35% EtOAc in hexane to afford compounds 3 (9 mg),
9 (6 mg), 11 (11 mg), 12 (20 mg), 13 (10 mg), and 15
(19 mg). Fr. 8 (7.1 g) was subjected to Si gel cc
(3 · 20 cm) eluted with CH2Cl2–MeOH mixtures of
increasing polarity (1:0, fr. 8-1, 250 ml; 49:1, fr. 8-2,
300 ml; 19:1, fr. 8-3, 1000 ml; 9:1, fr. 8-4, 500 ml; 4:1,
fr. 8-5, 500 ml). Fr. 8-3 was separated by preparative
HPLC [Phenomenex Luna 5 lm Silica (2),
250 mm · 10 mm] eluted with 5% acetone in CH2Cl2
to afford compound 14 (14 mg).
3.4.4. 3,22-Dioxo-20-taraxastene (4)
24
D
Colorless solid, mp 245–248 ꢁC; ½aꢁ : +63.9ꢁ
(CHCl3; c 0.2); UV kMeOH nm (log e): 236.0 (3.92); IR
max
1
KBr
max
m
cmꢀ1: 3052, 1707, 1677, 1642, 1384, 738. For H
and 13C NMR spectroscopic data, see Tables 1 and
2. EIMS 70 eV, m/z (rel. int.): 438 [M]+ (100), 423
(13), 395 (6), 368 (11), 353 (6), 243 (7), 236 (10), 219
(13), 205 (33), 189 (10), 163 (14), 152 (13), 107 (14),
97 (24); HREIMS, m/z found: 438.3503; calc. for
C30H46O2: 438.3500.
3.4.5. 3b-Acetoxy-11a,12a-epoxy-16-oxo-14-taraxerene
(5)
24
D
Colorless solid, mp >300 ꢁC; ½aꢁ : ꢀ39.3ꢁ (CHCl3; c
MeOH
max
KBr
max
0.2,); UV k
nm (log e): 243.0 (3.77); IR m
cmꢀ1
:
1
3053, 1734, 1683, 1375, 1247, 1031, 992, 738. For H
and 13C NMR spectroscopic data, see Tables 1 and 2.
EIMS 70 eV, m/z (rel. int.): 496 [M]+ (22), 481 (20),
478 (14), 463 (8), 436 (20), 403 (13), 372 (38), 356 (13),
312 (70), 294 (100), 279 (81), 175 (40), 148 (78), 135
(46); HREIMS, m/z found: 496.3546; calc. for
C32H48O4: 496.3554.
3.4. Compound identification
3.4.6. 3b-Acetoxy-25-methoxylanosta-8,23-diene (6)
26
D
3.4.1. 3b-Acetoxy-12,19-dioxo-13(18)-oleanene (1)
Colorless solid, mp 148–150 ꢁC; ½aꢁ : +30.4ꢁ (CHCl3;
24
D
KBr
max
Colorless solid, mp 244–247 ꢁC; ½aꢁ : ꢀ94.9ꢁ (CHCl3;
c 2.7); IR m
cmꢀ1: 1736, 1371, 1244, 1076, 1028, 979.
MeOH
max
1
c 1.0); UV k
1734, 1697, 1684, 1624, 1394, 1370, 1248, 1030, 1003,
nm (log e): 252.0 (3.83); IR m
cmꢀ1
:
KBr
max
For H and 13C NMR spectroscopic data, see Tables 1
and 2. EIMS 70 eV, m/z (rel. int.): 498 [M]+ (5), 466
(14), 451 (32), 406 (24), 391 (100), 309 (16), 297 (18),
109 (84); HREIMS, m/z found: 498.4073; calc. for
C33H54O3: 498.4075.
971, 902, 737, 705. For H and 13C NMR spectroscopic
1
data, see Tables 1 and 2. EIMS 70 eV, m/z (rel. int.): 496
[M]+ (30), 427 (100), 356 (16), 273 (14), 232 (62), 189
(30), 176 (28), 135 (25); HREIMS, m/z: found:
496.3557; calc. for C32H48O4: 496.3554.
3.4.7. Ursonic acid (13)
25
D
Colorless solid, mp 271–275 ꢁC; ½aꢁ : +56.7ꢁ (CHCl3;
cmꢀ1: 3400–2400, 3065, 1706, 1695, 1379,
KBr
max
3.4.2. 3b-Acetoxy-19(29)-taraxasten-20a-ol (2)
c 0.9); IR m
24
Colorless solid, mp 245–248 ꢁC; ½aꢁ : +55.3ꢁ
1387, 1318, 1278, 1257, 1238, 978, 740; 1H NMR
(400 MHz, CDCl3): 0.80 (s, H3-26), 0.84 (d,
D
(CHCl3; c 0.5); IR mKmaBxr cmꢀ1: 3464, 3091, 1734, 1642,
1380, 1370, 1249, 1037, 982, 900, 739. For 1H and
13C NMR spectroscopic data, see Tables 1 and 2.
EIMS 70 eV, m/z (rel. int.): 484 [M]+ (6), 466 (72),
451 (9), 426 (25), 406 (39), 391 (22), 363 (22), 337
(6), 303 (5), 295 (7), 269 (5), 255 (10), 229 (10), 217
(32), 202 (40), 189 (100), 173 (38), 133 (48), 121 (76),
107 (50); HREIMS, m/z found: 484.3927; calc. for
C32H52O3: 484.3919.
d
J = 6.4 Hz, H3-29), 0.93 (3H, d, J = 6.4 Hz, H3-30),
1.00 (s, H3-24), 1.03 (s, H3-25), 1.06 (s, H3-23 and H3-
27), 2.17 (d, J = 11.2 Hz, H-18), 2.36 (ddd, J = 16.0,
6.8, 3.6 Hz, Ha-2), 2.52 (ddd, J = 16.0, 10.8, 7.2 Hz,
Hb-2), 5.24 (t, J = 3.2 Hz, H-12); FABMS m/z (rel.
int.): 455 [M + H]+ (10), 425 (14), 407 (14), 248 (19),
203 (35), 154 (100). Identified by direct comparison
(1H NMR) with an authentic sample, which was synthe-
sized from ursolic acid (14) by Jones oxidation.
3.4.3. 3b-Acetoxy-21a,22a-epoxytaraxastan-20a-ol (3)
21
D
Colorless solid, mp >300 ꢁC; ½aꢁ : +5.6ꢁ (CHCl3; c
3.5. Antitumoral cytotoxic assay
KBr
max
0.6); IR m
cmꢀ1: 3513, 1728, 1386, 1375, 1247, 1014,
983, 936, 902, 869, 814. For H and 13C NMR spectro-
scopic data, see Tables 1 and 2. EIMS 70 eV, m/z (rel.
int.): 500 [M]+ (4), 482 (6), 466 (10), 442 (8), 440 (12),
422 (16), 411 (12), 379 (10), 353 (6), 299 (8), 257 (10),
234 (16), 203 (100), 189 (84), 175 (38), 135 (48), 121
(52), 95 (57); HREIMS, m/z found: 500.3845; calc. for
C32H52O4: 500.3868.
Human nasopharyngeal carcinoma HONE-1, oral
epidermoid carcinoma KB, and colorectal carcinoma
HT29 cells were maintained in RPMI-1640 medium sup-
plied with 5% fetal bovine serum. Cells in logarithmic
phase were cultured at a density of 5000 cells/ml/well
in a 24-well plate. The cells were exposed to various con-
centrations of the tested drugs for 72 h. The methylene
1